ARTICLE | Clinical News
Zevalin ibritumomab tiuxetan regulatory update
July 27, 2009 7:00 AM UTC
Spectrum said FDA accepted for review the resubmission of an sBLA for Zevalin ibritumomab tiuxetan as consolidation therapy after remission induction in previously untreated patients with follicular B...